EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Therapeutic Potential of Nanocurcumin in Mitigating Duloxetine‐Induced Hepatic Damage: Biochemical and Histopathological Insights

Hassanali Abedi, Maryam Jalali Jahromi, Zahra Mohammadzade, Bahareh Ebrahimi iD, Pegah Abdollahzadeh, Arash Hassannezhad, Farhad Sheikhnia iD, Hossein Kargar Jahromi

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.71102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Hassanali Abedi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Non-Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran. Hauptthemen laut MEDLINE: Duloxetine Hydrochloride, Curcumin, Chemical and Drug Induced Liver Injury, Liver. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jahrom University of Medical Sciences., Jahrom University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duloxetine, a serotonin‐norepinephrine reuptake inhibitor, commonly prescribed for depression and chronic pain, has been implicated in hepatotoxicity, primarily driven by oxidative stress and inflammatory responses. This has led to growing interest in naturally derived antioxidant compounds as potential protective strategies. The aim of this study was to evaluate the hepatoprotective potential of nanocurcumin against duloxetine‐induced liver injury in a controlled animal model. Male Wistar rats were divided into eight experimental groups, control, Solvent, curcumin 200 mg/kg, nanocurcumin 200 mg/kg, duloxetine 60 mg/kg, and treatment groups that simultaneously received duloxetine and nanocurcumin. Biochemical assays measured liver function enzymes (ALT, AST), oxidative stress markers (MDA, TOS), and antioxidant enzymes (SOD, GPx). Proinflammatory cytokine levels, TNF‐α were also measured and liver tissue was evaluated histologically. Duloxetine administration significantly increased liver enzymes, oxidative stress markers, and TNF‐α levels, along with histopathological evidence of liver injury. Concomitant treatment with nanocurcumin reduced these effects and attenuated these changes, as evidenced by normalization of biochemical indices, enhanced antioxidant defense, suppression of proinflammatory cytokines, and preservation of liver structure. Nanocurcumin exhibits potent hepatoprotective effects against duloxetine‐induced liver injury, likely through enhancement of antioxidant capacity and modulation of inflammatory responses. These findings support its potential as an adjunctive therapy to duloxetine to mitigate hepatic side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Duloxetine HydrochlorideCurcuminChemical and Drug Induced Liver InjuryLiverAnimalsMaleRats, WistarRatsOxidative StressAntioxidantsNanoparticles

Stichwörter der Autor:innen

duloxetine hydrochlorideliver injurynanomedicineoxidative stress

Substanzen

Duloxetine HydrochlorideCurcuminAntioxidantsnanocurcumin

Autor:innen und Institutionen

  • Research Center for Non-Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.
  • Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
  • Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Student Research Committee, Urmia University of Medical Sciences, Urmia.
  • Department of Clinical Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

ORCID-Profile: Bahareh Ebrahimi, Farhad Sheikhnia

Förderung

  • Jahrom University of Medical Sciences.
  • Jahrom University of Medical Sciences

Zitieren

APA

Abedi, H., Jahromi, M. J., Mohammadzade, Z., Ebrahimi, B., Abdollahzadeh, P., Hassannezhad, A., Sheikhnia, F., & Jahromi, H. K. (2026). Therapeutic Potential of Nanocurcumin in Mitigating Duloxetine‐Induced Hepatic Damage: Biochemical and Histopathological Insights. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.71102

Vancouver

Abedi H, Jahromi MJ, Mohammadzade Z, Ebrahimi B, Abdollahzadeh P, Hassannezhad A, et al. Therapeutic Potential of Nanocurcumin in Mitigating Duloxetine‐Induced Hepatic Damage: Biochemical and Histopathological Insights. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.71102

BibTeX
@article{Abedi2026,
  author = {Abedi, Hassanali and Jahromi, Maryam Jalali and Mohammadzade, Zahra and Ebrahimi, Bahareh and Abdollahzadeh, Pegah and Hassannezhad, Arash and Sheikhnia, Farhad and Jahromi, Hossein Kargar},
  title = {Therapeutic Potential of Nanocurcumin in Mitigating Duloxetine‐Induced Hepatic Damage: Biochemical and Histopathological Insights},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.71102}
}
Kostenlos starten →